INSM2 and metabolic dysfunction-associated steatotic liver disease: Congruently, we found significant enhancement of hepatic INSM2 and USF1 expression, supporting the idea that USF1 transcriptionally regulates INSM2 and uc.372 expression in the liver of NAFLD patients (Fig. 8d, e).